Literature DB >> 23224225

[2010 annual report of the German pacemaker and defibrillator register: section pacemakers and AQUA-Institute for Applied Quality Improvement and Research in Health Care Ltd].

A Markewitz1.   

Abstract

Mesh：

Year:  2012        PMID： 23224225     DOI： 10.1007/s00399-012-0241-7

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN： 0938-7412


× No keyword cloud information.
  13 in total

1.  Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality.

Authors:  Johannes B van Rees; C Jan Willem Borleffs; Mihály K de Bie; Theo Stijnen; Lieselot van Erven; Jeroen J Bax; Martin J Schalij
Journal:  J Am Coll Cardiol       Date:  2011-02-01       Impact factor: 24.094

2.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

Authors:  Michael R Bristow; Leslie A Saxon; John Boehmer; Steven Krueger; David A Kass; Teresa De Marco; Peter Carson; Lorenzo DiCarlo; David DeMets; Bill G White; Dale W DeVries; Arthur M Feldman
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

3.  Here we go again--another failure of postmarketing device surveillance.

Authors:  Robert G Hauser
Journal:  N Engl J Med       Date:  2012-02-14       Impact factor: 91.245

4.  Defibrillation efficacy testing: long-term follow-up and mortality.

Authors:  Dominic A M J Theuns; Tamas Szili-Torok; Luc J Jordaens
Journal:  Europace       Date:  2005-07-18       Impact factor: 5.214

5.  Clinical predictors of Fidelis lead failure: report from the Canadian Heart Rhythm Society Device Committee.

Authors:  David H Birnie; Ratika Parkash; Derek V Exner; Vidal Essebag; Jeffrey S Healey; Atul Verma; Benoit Coutu; Teresa Kus; Iqwal Mangat; Felix Ayala-Paredes; Pablo Nery; George Wells; Andrew D Krahn
Journal:  Circulation       Date:  2012-02-06       Impact factor: 29.690

6.  The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry.

Authors:  James V Freeman; Yongfei Wang; Jeptha P Curtis; Paul A Heidenreich; Mark A Hlatky
Journal:  J Am Coll Cardiol       Date:  2010-09-28       Impact factor: 24.094

7.  Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry.

Authors:  Dan D Matlock; Pamela N Peterson; Yongfei Wang; Jeptha P Curtis; Matthew R Reynolds; Paul D Varosy; Frederick A Masoudi
Journal:  Arch Intern Med       Date:  2012-04-23

8.  Physician procedure volume and complications of cardioverter-defibrillator implantation.

Authors:  James V Freeman; Yongfei Wang; Jeptha P Curtis; Paul A Heidenreich; Mark A Hlatky
Journal:  Circulation       Date:  2011-11-17       Impact factor: 29.690

9.  Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?

Authors:  Joseph J Germano; Matthew Reynolds; Vidal Essebag; Mark E Josephson
Journal:  Am J Cardiol       Date:  2006-03-09       Impact factor: 2.778

10.  Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.

Authors:  Bruce L Wilkoff; James R Cook; Andrew E Epstein; H Leon Greene; Alfred P Hallstrom; Henry Hsia; Steven P Kutalek; Arjun Sharma
Journal:  JAMA       Date:  2002-12-25       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.